Efungumab
Efungumab
Efungumab (pronunciation: /ɛˈfʌŋɡʊmæb/) is a type of monoclonal antibody used in the treatment of invasive aspergillosis, a serious fungal infection.
Etymology
The term 'Efungumab' is derived from the Latin words 'efungus', meaning 'fungus', and 'mab', an abbreviation for 'monoclonal antibody'.
Usage
Efungumab is used in combination with other antifungal drugs to treat invasive aspergillosis. It works by binding to a specific protein on the surface of the fungus, inhibiting its growth and spread.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Invasive aspergillosis: A severe infection caused by the fungus Aspergillus.
- Antifungal drugs: Medications used to treat fungal infections.
See Also
External links
- Medical encyclopedia article on Efungumab
- Wikipedia's article - Efungumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski